'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum
Retrieved on:
Monday, November 6, 2023
Global Medical Device Nomenclature, Patient, Ulcer, Education, PN, Prickle (protein), Neuropathic pain, Neurology, Assistant, Facial muscles, Physician, Prevalence, IDF, Burning Sensations, Health, International Diabetes Federation, DPN, Type 2 diabetes, WDD, Finger, Foot, Hypoesthesia, Senior, AMA, Prediabetes, Paresthesia, Quality of life, Bethesda Hospital, The, Extremities, Risk, P&G, Peripheral neuropathy, Lyceum, Trial of the century, B, Pharmacist, Ankle, Amputation, Diagnosis, Consultant, Infection, Dietary supplement, Pharmaceutical industry, Diabetes
The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
Key Points:
- The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
- With Diabetes Mellitus Type 2 being the leading cause of PN, its increasing prevalence is closely linked to the rise in the number of diabetics.
- B vitamin deficiency and polymedication are other high-risk factors along with diabetes, leading to peripheral nerve damage.
- Patients should be educated about the importance of regular foot and DPN examinations, glycemic control, and adherence to prescribed medications.